Author:
Giaddui Tawfik,Chen Wenzhou,Yu Jialu,Lin Liyong,Simone Charles B.,Yuan Lulin,Gong Yutao U. T.,Wu Q. Jackie,Mohan Radhe,Zhang Xiaodong,Bluett Jaques B.,Gillin Michael,Moore Kevin,O’Meara Elizabeth,Presley Jennifer,Bradley Jeffrey D.,Liao Zhongxing,Galvin James,Xiao Ying
Funder
Pennsylvania Department of Health
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference20 articles.
1. Bradley J, Paulus R, Komaki R et al. A randomized phase III comparison of standard- (60 Gy) versus high dose (74 Gy) conformal radiotherapy with concurrent and consolidation carboplatin/paclitaxel in patients with stage IIIA/IIIB non-small cell lung cancer. Radiation therapy oncology group,.2007.
2. Liao Z, Bradley J, Choi N et al. RTOG 1308: Phase III randomized trial comparing overall survival after photon versus proton chemotherapy for inoperable stage II-IIIB NSCLC. 2015
https://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=1308
3. Siegel RL, Miller KDJA. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
4. Wink KC, Roelofs E, Solberg T, Lin L, Simone 2nd CB, Jakobi A, et al. Particle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literature. Front Oncol. 2014;4:292.
5. Simone 2nd CB, Rengan R. The use of proton therapy in the treatment of lung cancers. Cancer J. 2014;20(6):427–32.
Cited by
80 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献